SFI Health™ EMEA Announces the Launch in Portugal of Equazen® Food Supplements, the Brand Developed to Support Cognitive Needs
SFI Health™ EMEA, the regional entity of SFI Health™, a global leader in natural healthcare, is excited to announce that Equazen® products will soon be available in Portugal. The company specializes in clinically researched products in microbiome, cognition, and well-being.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250226258206/en/
Discover Equazen®, a science-based food supplement designed and studied to help nourish, enhance, and support the human brain’s potential across all life stages. (Graphic: Business Wire)
This marks a significant step forward in SFI Health™ EMEA's ongoing European expansion, following the exclusive license-in agreement signed in February 2024 with Eqyon Healthcare Solutions, a local distributor specialized in healthcare products. Under the terms of the agreement, Eqyon will use its sales and marketing expertise to distribute Equazen® range in pharmacies and parapharmacies.
Equazen® is a trusted global brand offering science-based nutritional solutions to support brain health and cognitive function. Equazen® products feature a unique combination of essential fatty acids (Omega 3 and Omega 6), proven in over 15 clinical studies to support learning, concentration, and healthy brain development.
Matthew Brabazon, GM of SFI Health™ EMEA commented: “We are excited to offer our science-backed Equazen® solutions to Portuguese consumers, who are becoming more proactive in supporting their cognitive needs. Our entry in Portugal is another step of our development plan to grow in the region by widening our partners network and customer base.”
Mr. Nuno Carvalho, CEO of Eqyon, added: “We believe Equazen® products will make a meaningful impact in our market, thanks to their high-quality ingredients and well-documented benefits. We are proud to bring Equazen® back to Portugal and will work closely with SFI Health™ EMEA to strengthen confidence in natural solutions among healthcare professionals and consumers."
Brain health supplements are one of the fastest growing segments in the global food supplements market: in Europe, between 2023 and 2030, the market is expected to grow at a compound annual rate of 12.5%, driven by increased awareness of cognitive and mental health.
SFI Health™ EMEA and Equazen® are present in several markets, including Spain, United Kingdom, Switzerland, Poland, Czech, Slovak, the Netherlands, the Nordics and the Baltics. The company aims at further widening Equazen® distribution to unlock the potential sales of the brand and make the most of the growing brain health supplements market.
About SFI Health™
SFI Health™ is a global leader in natural healthcare, specialized in the design, development and commercialization of clinically researched products in the areas of microbiome, cognition and wellbeing.
Guided by the belief in the healing potential of natural products, SFI Health™combines a rigorous pharma-based approach with the benefits of naturally sourced solutions.
An extensive network of trusted business partners enables the company, headquartered in Australia, to market its own brands, reaching consumers in over 50 countries. The EMEA SFI Health™ regional office in Lugano, Switzerland, manages commercial operations across Europe, Middle East and Africa.
SFI Health™ is committed to fostering confidence in natural healthcare by sharing state-of-the-art research, technical expertise and comprehensive sales & marketing resources with consumers, healthcare professionals and partners worldwide.
For more information go to sfihealth.com or follow us SFI Health on LinkedIn.
About Eqyon Healthcare Solutions
Eqyon Healthcare Solutions is a customer-focused company dedicated to optimizing healthcare supply chains. By leveraging strategic partnerships and innovative solutions, we help healthcare providers, pharmacies, and institutions improve efficiency, reduce costs, and enhance patient care.
We are committed to addressing the challenges within the healthcare sector through effective, evidence-based solutions. As part of this commitment, we are excited to reintroduce Equazen® to the Portuguese market. Equazen® aligns with our mission to offer natural, scientifically-backed products that promote cognitive health and well-being. In partnership with trusted global brands like Equazen®, we expand access to high-quality, proven solutions that improve lives.
At Eqyon Healthcare Solutions, we aim to be a leading provider of efficient healthcare solutions, continuously transforming challenges into opportunities and ensuring excellence in customer care.
For more information, visit eqyon.eu and follow Eqyon Healthcare Solutions on LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250226258206/en/
Contacts
For more information
SFI Health™ EMEA
Elisabetta Bianchi
e-mail address: elisabetta.bianchi@sfihealth.com
Eqyon
Nuno Carvalho & CEO
e-mail address: nuno.carvalho@eqyon.eu
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SLB Announces Debt Exchange Offer27.2.2025 13:50:00 EET | Press release
Schlumberger Limited (“SLB”) (NYSE: SLB) today announced that Schlumberger Holdings Corporation, an indirect wholly owned subsidiary of SLB (“SHC”), has commenced offers to exchange certain series of notes listed below (the “Existing SISA Notes”), issued by Schlumberger Investment S.A. (“SISA”), for up to $2,000,000,000 aggregate principal amount (such amount, as it may be amended, the “Maximum Exchange Amount”) of new notes listed below (the “New SHC Notes”), to be issued by SHC, and to be fully and unconditionally guaranteed on a senior unsecured basis by SLB. The offers to exchange each series of Existing SISA Notes for the corresponding series of New SHC Notes are collectively referred to herein as the “Offers.” The Offers are made upon the terms and subject to the conditions set forth in the exchange offer memorandum and consent solicitation statement, dated February 27, 2025 (as may be amended or supplemented from time to time, the “Exchange Offer Memorandum”). Capitalized terms
Compass Pathways Announces Fourth Quarter and Full-Year 2024 Financial Results and Business Highlights27.2.2025 13:30:00 EET | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today reported its financial results for the fourth quarter and full year 2024 and provided an update on recent progress across its business. “We are excited that the first data readout from our pivotal phase 3 COMP360 program in treatment resistant depression continues on track with top-line 6-week data expected next quarter,” said Kabir Nath, Chief Executive Officer. “Building on last year’s promising phase 2a data in PTSD and the resources now available from the January financing, we are advancing plans to develop a late-stage clinical program for PTSD with the goal of getting COMP360 to patients as quickly as possible. The need for a new approach to treatment remains significant in TRD and PTSD and we believe COMP360 represents a novel treatment option in these mental health conditions.” Business Highlights The pivotal phase 3 clinical
Hansen and RiksTV Extend Partnership to Accelerate Customer Care and Billing Cloud Transformation Journey27.2.2025 13:00:00 EET | Press release
Hansen Technologies (ASX:HSN), a leading global provider of software and services to the communications, energy, and water industries, is pleased to announce that longtime customer RiksTV has extended its commitment to Hansen. Under the terms of the agreement, the company will upgrade and transform to the latest version of Hansen CCB in the cloud, part of the Hansen Suite for Communications, Technology & Media. As a result of this transformation, RiksTV, one of Norway’s leading pay-TV and streaming providers, will achieve greater business flexibility by moving from Oracle to a more flexible open-source solution. This is in line with the organisation’s cloud transformation journey via AWS. As a result of the transition, RiksTV expects to achieve a rapid ROI of 18 months on the transition – while placing them firmly on the path towards a cloud-native architecture. Hansen CCB provides flexible rating, billing, and customer care for communications and pay-TV service providers. Hansen CCB a
BeiGene Announces Fourth Quarter and Full Year 2024 Financial Results and Business Updates27.2.2025 13:00:00 EET | Press release
BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced financial results and corporate updates from the fourth quarter and full year 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250227911272/en/ (Graphic: Business Wire) “Our fourth quarter and full year results demonstrate our tremendous growth as a global oncology powerhouse, reinforced by the continued success of BRUKINSA and the development of one of the most prolific solid tumor pipelines in oncology with multiple data readouts expected this year,” said John V. Oyler, Co-Founder, Chairman, and CEO at BeiGene. “BRUKINSA is now the unequivocal leader in new CLL patient starts in the U.S., holds the broadest label of any BTK inhibitor and serves as the cornerstone of our hematology franchise, showing immense promise as a backbone alongside our late stage BCL2 inhibitor
Infobip Demonstrates How Network APIs are Driving Innovation at MWC27.2.2025 11:29:00 EET | Press release
At this year’s Mobile World Congress (MWC), global cloud communications platform Infobip is tapping into pioneering themes and activities spearheaded by the mobile industry association GSMA, highlighting how Network APIs drive innovation. Following several successful partnerships launching Camara-compliant Network APIs under the GSMA Open Gateway initiative, Infobip is at the forefront of helping telcos make the most of Network APIs. For instance, Infobip recently helped a major Brazilian operator to implement Number Verify (NV) and Silent Mobile Verification (SMV). This helps speed up verification while increasing conversion because there is less chance of user error. The new process also reduces the risks of fraud. The telecommunications company enhanced its onboarding process by integrating SMV into its engagement app, boosting conversion rates from 80% (using SMS-based OTP) to over 99%, ensuring seamless user validation for nearly 1.5 million monthly users. In addition, Infobip has
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom